 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | anti-CD19 iCAR NK cells / Allife Medical Science and Technology, Anti-CD19 CAR NK Cells / Allife Medical Science and Technology
Trial initiation date: Study of Anti-CD19 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma (clinicaltrials.gov) - Jan 30, 2019
P1, N=9, Not yet recruiting, Sponsor: Allife Medical Science and Technology Co., Ltd.
Initiation date: Nov 2018 --> Mar 2019
- | anti-CD19 iCAR NK cells / Allife Medical Science and Technology, Anti-CD19 CAR NK Cells / Allife Medical Science and Technology
New P1 trial: Study of Anti-CD19 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma (clinicaltrials.gov) - Sep 30, 2018
P1, N=9, Not yet recruiting, Sponsor: Allife Medical Science and Technology Co., Ltd.